Amino acid misincorporation in recombinant biopharmaceutical products
Robert P Harris1, Peter M Kilby1
1Syngenta, Jealott's Hill International Research Centre, Bracknell, Berks RG42 6EY, UK.
Abstract:
Microbial and mammalian host systems have been used extensively for the production of protein biotherapeutics. Generally these systems rely on the production of a specific gene sequence encoding one therapeutic product. Analysis of these protein products over many years has proven that this was not always the case, with multiple species of the intended product being produced due to amino acid misincorporation or mistranslation during biosynthesis of the protein. This review is the first to give a comprehensive overview of the occurrence and analysis of these misincorporations. Furthermore, using the latest data on misincorporation in native human proteins we explore potential considerations for producing a specification for misincorporation for the development of a human biotherapeutic protein product in a production environment.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
11:51Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
Published on: April 27, 2018
Related Concept Videos
Production of Pharmaceuticals
Improving Translational Accuracy
Recombinant DNA
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Amino Acid Biosynthetic Pathways
Leaky Scanning
